Positive feedback between arginine methylation of YAP and methionine transporter SLC43A2 drives anticancer drug resistance
Abstract Yes-associated protein (YAP) activation confers resistance to chemotherapy and targeted therapy. Methionine participates in cellular processes by converting to methyl donor for the methylation of DNA, RNA and protein. However, it remains unclear whether methionine affects drug resistance by...
Saved in:
Main Authors: | Xia-Lu Hong, Chen-Kai Huang, Hui Qian, Chen-Hong Ding, Fang Liu, Huan-Yu Hong, Shu-Qing Liu, Si-Han Wu, Xin Zhang, Wei-Fen Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-024-55769-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opposing roles of p38α-mediated phosphorylation and PRMT1-mediated arginine methylation in driving TDP-43 proteinopathy
by: Mari Aikio, et al.
Published: (2025-01-01) -
Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression
by: Du Jiamin, et al.
Published: (2022-09-01) -
SLC7A5 is required for cancer cell growth under arginine-limited conditions
by: Kyle N. Dunlap, et al.
Published: (2025-01-01) -
Methionine-driven methylation modification overcomes plasmid-mediated high-level tigecycline resistance
by: Dan Fang, et al.
Published: (2025-01-01) -
Aberrant Hepatic Methionine Metabolism and Gene Methylation in the Pathogenesis and Treatment of Alcoholic Steatohepatitis
by: Charles H. Halsted, et al.
Published: (2012-01-01)